Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Observational × pertuzumab × Clear all

Status

Sponsor Class

OTHER 8 INDUSTRY 3 NETWORK 1

Study Type

Interventional 7 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Gene Expression Profiling 74 Polymerase Chain Reaction 44 Microarray Analysis 40 Amplified Fragment Length Polymorphism Analysis 37 Immunohistochemistry 35 Flow Cytometry 30 Reverse Transcriptase Polymerase Chain Reaction 22 DNA Methylation 16 Blotting, Western 15 Cytogenetic Analysis 14 Base Sequence 12 Psychiatric Rehabilitation 11 In Situ Hybridization, Fluorescence 10 Immunologic Techniques 9 Enzyme-Linked Immunosorbent Assay 7 Mental Status and Dementia Tests 6 Comparative Genomic Hybridization 6 Watchful Waiting 5 Pharmacogenomic Testing 5 Mass Spectrometry 5 Gene Rearrangement 5 Chromosome Mapping 5 Surveys and Questionnaires 4 Specimen Handling 4 Rituximab 4 Paclitaxel 4 Interviews as Topic 4 In Situ Hybridization 4 Immunoenzyme Techniques 4 Therapeutics 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01850628 2021-10-05

NSABP Biospecimen Discovery Project

NSABP Foundation Inc

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡